The Effect of Cognitive Functional Therapy on Patients With Non-specific Chronic Low Back Pain

December 11, 2018 updated by: University of Limerick

The Effect of Cognitive Functional Therapy on Patients With Non-specific Chronic Low Back Pain: a Multi-centre Randomized Trial

The purpose of this study is to evaluate whether individual cognitive functional therapy (CFT), when compared to group exercise classes is effective in reducing pain and disability in patients with non-specific chronic low back pain.

Study Overview

Detailed Description

A multi-centre randomised study with 6 month, 12 month and 36 month follow up will be used. Patient with non- specific chronic low back pain will be assessed for eligibility. The patients fitting the inclusion criteria will be randomised to receive either the individual CFT or the group classes consisting of education and exercise. Participants' pain, disability, socio-economic status, beliefs, fear, catastrophizing, self-efficacy, general health, stress levels, as well as number and cost of treatments will be evaluated using a range of outcome measures at the start and on completion of the treatment. Patients will receive another copy of the questionnaires in the post at 6 month, 12 months and 36 months after treatment to reassess clinical outcomes. If a participant does not respond to follow-up, they will be telephoned to ask if they wish to complete the questionnaires.

Study Type

Interventional

Enrollment (Actual)

208

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connacht
      • Mayo, Connacht, Ireland, 0000
        • Ballina Primary Care Centre
      • Mayo, Connacht, Ireland, 0000
        • Claremorris Primary Care Centre
      • Mayo, Connacht, Ireland, 0000
        • Mayo General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged between 18 and 75
  • Chronic low back pain greater than 6 months duration
  • Score greater than 14% for disability on Oswestry Disability Index (ODI)
  • Independently mobile (with or without aids), to be capable of participating in a rehabilitation programme

Exclusion Criteria:

  • Primary pain area is not the lumbar spine (from T12-buttocks)
  • Leg pain as the primary problem (nerve root compression or disc prolapse with true radicular pain/radiculopathy, lateral recess/central or spinal stenosis with primary leg pain)
  • <6 months post lumbar spine or lower limb or abdominal surgery
  • Pain relieving procedures such as injection based therapy (e.g epidurals) and day case procedures (e.g rhizotomy) in the last 3 months
  • Pregnancy
  • Rheumatologic/inflammatory disease (e.g. rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis, lupus, scheuermann's disease)
  • Progressive neurological disease (e.g. multiple sclerosis (MS), parkinson's disease (PD), motor neuron disease (MND)
  • Unstable cardiac conditions
  • Red flag disorders like malignancy/cancer, acute traumas like fracture (<6 months ago) or infection, spinal cord compression/cauda equina

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Individual Cognitive Functional Therapy
The intervention being tested has four main components: (1) a cognitive component, for each patient, their vicious cycle of pain will outlined in a diagram based on their findings from the examination and the Orebro Musculoskeletal Pain Screening Questionnaire; (2) specific movement exercises designed to normalize maladaptive movement behaviours; (3) targeted functional integration of activities in their daily life previously, reported to be avoided or provocative by the patient; and (4) a physical activity and lifestyle programme.
Cognitive functional therapy (CFT) is a novel, patient centred behavioural intervention which addresses multiple dimensions in non-specific chronic low back pain (NSCLBP). It combines a functional behavioural approach of normalising provocative postures and movements while discouraging pain behaviours, with cognitive restructuring of the NSCLBP problem.
Active Comparator: Group Exercise Classes
6 classes will take place in total. The class has 3 components each week. First, a 30 minute talk and discussion on chronic pain, and some tips for participants. Second, a 40 minute exercise circuit, involving aerobic exercise, and gentle stretching and strengthening exercises. Finally, a 5 minute relaxation/mindfulness session will take place at the end. The total time involved is approximately 1 hour and 15 minutes.
Each class involves a combination of education, exercise and relaxation/mindfulness. The education topics include pain and the nervous system, posture and ergonomics, exercise and relaxation and sleep. The exercise component includes 10 stations of a combination of aerobic, strength and flexibility exercises. These will be walking/jogging on the spot, mini-squats, sit to stands, wall push ups, bridging, step-ups and a combination of leg and low back stretches. The relaxation/mindfulness component will take place at the end of each class and will involve breathing and relaxation of the body.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Oswestry Disability Index (ODI)
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Used to assess change in disability levels over the course of the trial and follow-up
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numerical rating scale (NRS)
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Measures pain intensity
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Socio-economic Conditions Index
Time Frame: Baseline
Measures socio-economic status
Baseline
Back Pain Beliefs Questionnaire
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Assess a person's beliefs about their back pain
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Physical activity subscale of the Fear-Avoidance Beliefs Questionnaire (FABQ)
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Assesses a person's level of fear-avoidance beliefs regarding physical activities.
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
The catastrophising subscale of the Coping Strategies Questionnaire (CSQ)
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Assesses level of pain catastrophizing.
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Pain Self- Efficacy Questionnaire (PSEQ)
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Assesses level of pain self-efficacy
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Subjective Health Complaints Inventory (SHC)
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Assess level of subjective health complaints
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Nordic Musculoskeletal Screening Questionnaire
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Assesses areas of bodily pain
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Stress subscale of the Depression, Anxiety and Stress scale (DASS 21)
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Assesses patient's stress levels.
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Patient Satisfaction Questionnaire
Time Frame: At 8-14 weeks
Assesses patient satisfaction
At 8-14 weeks
Short-Form Orebro Musculoskeletal Screening Questionnaire (OMSQ)
Time Frame: Measured at baseline
Stratifies patients into low, medium or high risk of delayed pain recovery and chronicity.
Measured at baseline
Medication usage
Time Frame: Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
To assess changes in levels of medication used.
Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Economic evaluation
Time Frame: 6, 12 and 36 months
Assesses direct and indirect costs of both treatment arms to see which is more cost-effective.
6, 12 and 36 months
Level of co-interventions
Time Frame: Baseline, post-intervention (at 8-14 weeks), 6, 12 and 36 months
Assesses the number/type of healthcare services availed of throughout the intervention period.
Baseline, post-intervention (at 8-14 weeks), 6, 12 and 36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Dr Kieran O' Sullivan, PhD, University of Limerick
  • Principal Investigator: Mary O'Keeffe, BSc Physio, University of Limerick
  • Principal Investigator: Prof. Peter O'Sullivan, Professor, Curtin University
  • Principal Investigator: Dr Norelee Kennedy, PhD, University of Limerick
  • Principal Investigator: Prof. Wim Dankaerts, Professor, KU Leuven

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2014

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

April 30, 2014

First Submitted That Met QC Criteria

May 22, 2014

First Posted (Estimate)

May 23, 2014

Study Record Updates

Last Update Posted (Actual)

December 12, 2018

Last Update Submitted That Met QC Criteria

December 11, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Clinical Trials on Individual Cognitive Functional Therapy

3
Subscribe